一位新西兰父亲正在就他儿子与Isotretinoin有关的严重的OCD被拒绝赔偿提出上诉,寻求法律先例。 A New Zealand father is appealing a denial of compensation for his son’s severe OCD linked to Isotretinoin, seeking a legal precedent.

新西兰父亲John在儿子Harry于2016年使用Isotretinoin后发展了严重的OCD之后,正在对事故赔偿公司提起法律诉讼,要求赔偿。 A New Zealand father, John, is pursuing legal action against the Accident Compensation Corporation (ACC) for compensation after his son, Harry, developed severe OCD following Isotretinoin use in 2016. 哈利,曾经是一个高成就的学生和钢琴家 现在遭受了极端的仪式 比如5小时的淋浴和不停的洗手 使得身体接触无法进行 Harry, once a high-achieving student and pianist, now suffers from extreme rituals like five-hour showers and constant handwashing, making physical contact impossible. 虽然Medsafe承认有100多份全球报告将毒品与OCD联系起来,但报告并未证实其因果关系。 Though Medsafe acknowledges over 100 global reports linking the drug to OCD, it does not confirm causation. 2017年,行政协调会驳回了这一要求,指出停止药物治疗六周后出现症状,但2025年,高等法院准予John上诉许可,这有可能开创世界第一的法律先例。 ACC rejected the claim in 2017, citing symptom onset six weeks after stopping the medication, but in 2025, the High Court granted John leave to appeal, potentially setting a world-first legal precedent.